| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abelcet
|
Boyle, James A.
|
|
1999
|
|
4 |
p. 427-428
|
artikel
|
| 2 |
Absorption Characteristics of Sustained-Release 4-Aminopyridine (Fampridine SR) in Patients with Chronic Spinal Cord Injury
|
Segal, Jack L.
|
|
2000
|
|
4 |
p. 402-409
|
artikel
|
| 3 |
Acetaminophen Controlled-Release Sprinkles versus Acetaminophen Immediate-Release Elixir in Febrile Children
|
Wilson, John T.
|
|
2000
|
|
4 |
p. 360-369
|
artikel
|
| 4 |
A Clinical Evaluation of a New Concentrated Antacid. I. Effects on Gastric pH
|
Powell, Robert L.
|
|
1971
|
|
4 |
p. 288-295
|
artikel
|
| 5 |
A Clinical Evaluation of a New Concentrated Antacid. II. Safety and Efficacy in Duodenal Ulcer Patients
|
Powell, Robert L.
|
|
1971
|
|
4 |
p. 296-300
|
artikel
|
| 6 |
A Clinical Evaluation of Glycopyrrolate, a New Anticholinergic Agent
|
Slanger, Alexander
|
|
1962
|
|
4 |
p. 215-222
|
artikel
|
| 7 |
A Comment on “Grapefruit-Drug Interactions
|
Blum, Richard S.
|
|
2007
|
|
4 |
p. 536-536
|
artikel
|
| 8 |
A Comparative Study of the Effects of Methaqualone and Glutethimide on Sleep in Male Chronic Insomniacs
|
Goldstein, Leonide
|
|
1970
|
|
4 |
p. 258-268
|
artikel
|
| 9 |
A Comparison of the Gastrointestinal Effects of the Nitrogen-Containing Bisphosphonates Pamidronate, Alendronate, and Olpadronate in Humans
|
Twiss, I. M.
|
|
2006
|
|
4 |
p. 483-487
|
artikel
|
| 10 |
Acute Clinical Assay for Appetite Suppression
|
Herting, Robert L.
|
|
1966
|
|
4 |
p. 232-236
|
artikel
|
| 11 |
Addition of Cilostazol to Aspirin and a Thienopyridine for Prevention of Restenosis After Coronary Artery Stenting: A Meta-Analysis
|
Jennings, Douglas L.
|
|
2010
|
|
4 |
p. 415-421
|
artikel
|
| 12 |
Adherence to Available Clinical Practice Guidelines for Initiation of Antihypertensive Medication in Patients With or Without Diabetes Mellitus and Other Comorbidities in Taiwan
|
Chou, Chih-Chieh
|
|
2012
|
|
4 |
p. 576-585
|
artikel
|
| 13 |
A Dose-Ranging Study of Gentamicin Pharmacokinetics: Implications for Extended Interval Aminoglycoside Therapy
|
McNamara, David R.
|
|
2001
|
|
4 |
p. 374-377
|
artikel
|
| 14 |
Adrenocortical Steroids in the Treatment of Kerosene Pneumonia
|
Verhulst, Henry L.
|
|
1961
|
|
4 |
p. 147-149
|
artikel
|
| 15 |
Age and Gender Effects on the Pharmacokinetics and Pharmacodynamics of Ramelteon, a Hypnotic Agent Acting via Melatonin Receptors MT1 and MT2
|
Greenblatt, David J.
|
|
2007
|
|
4 |
p. 485-496
|
artikel
|
| 16 |
Altered Clearance of Theophylline in Children with Down Syndrome: A Case Series
|
Stowe, Cindy D.
|
|
1999
|
|
4 |
p. 359-365
|
artikel
|
| 17 |
Altered Methylprednisolone Pharmacodynamics in Healthy Subjects With Histamine N-Methyltransferase C314T Genetic Polymorphism
|
Hon, Yuen Yi
|
|
2006
|
|
4 |
p. 408-417
|
artikel
|
| 18 |
American College Of Clinical Pharmacology
|
|
|
2005
|
|
4 |
p. 483-484
|
artikel
|
| 19 |
American College of Clinical Pharmacology Position Statement on the Use of Microdosing in the Drug Development Process
|
Bertino, Joseph S.
|
|
2007
|
|
4 |
p. 418-422
|
artikel
|
| 20 |
American College of Clinical Pharmocology
|
|
|
2004
|
|
4 |
p. 439-440
|
artikel
|
| 21 |
Δ8-and Δ9-Tetrahydrocannabinol: Effects on Cultured Human Leucocytes
|
Neu, Richard L.
|
|
1970
|
|
4 |
p. 228-230
|
artikel
|
| 22 |
Anidulafungin Does Not Require Dosage Adjustment in Subjects With Varying Degrees of Hepatic or Renal Impairment
|
Dowell, James A.
|
|
2007
|
|
4 |
p. 461-470
|
artikel
|
| 23 |
Antiasthmatic Action of Sympathomimetics: A Review of the Literature on their Bronchopulmonary Effects
|
Aviado, Domingo M.
|
|
1970
|
|
4 |
p. 217-221
|
artikel
|
| 24 |
Antihypertensive and Renin Angiotensin Effects Of Metolazone With and Without Propranolol
|
Sambhi, Mohinder P.
|
|
1977
|
|
4 |
p. 214-224
|
artikel
|
| 25 |
Antiplatelet Activity During Coadministration of the Selective Serotonin Reuptake Inhibitor Paroxetine and Aspirin in Male Smokers: A Randomized, Placebo-Controlled, Double-blind Trial
|
Kotzailias, Nicole
|
|
2006
|
|
4 |
p. 468-475
|
artikel
|
| 26 |
A Pilot Study of Netilmicin Pharmacokinetics During Continuous Venovenous Hemodiafiltration
|
Syka, Maria
|
|
2005
|
|
4 |
p. 477-482
|
artikel
|
| 27 |
Application of Nonparametric Procedure for Bioassay Data to the Evaluation of Analgesics in Man
|
Fuccella, Luciano M.
|
|
1977
|
|
4 |
p. 177-185
|
artikel
|
| 28 |
Aprepitant Pharmacokinetics and Assessing the Impact of Aprepitant on Cyclophosphamide Metabolism in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation
|
Bubalo, Joseph S.
|
|
2012
|
|
4 |
p. 586-594
|
artikel
|
| 29 |
Are Literature References Sufficient for Dose Recommendations? An FDA Case Study of Efavirenz and Rifampin
|
DiGiacinto, Jennifer L.
|
|
2008
|
|
4 |
p. 518-523
|
artikel
|
| 30 |
Assessment of QTc Prolongation for Non-Cardiac-Related Drugs from a Drug Development Perspective
|
Bonate, Peter L.
|
|
1999
|
|
4 |
p. 349-358
|
artikel
|
| 31 |
Assessment of the Effects of Renal Impairment on the Pharmacokinetic Profile of Fesoterodine
|
Malhotra, Bimal
|
|
2009
|
|
4 |
p. 477-482
|
artikel
|
| 32 |
Assessment of Visual Analog versus Categorical Scale for Measurement of Osteoarthritis Pain
|
Averbuch, Mordechai
|
|
2004
|
|
4 |
p. 368-372
|
artikel
|
| 33 |
A Study of the Interaction Potential of Azithromycin and Clarithromycin with Atorvastatin in Healthy Volunteers
|
Amsden, Guy W.
|
|
2002
|
|
4 |
p. 444-449
|
artikel
|
| 34 |
Bendroflumethiazide Diuresis in Congestive Heart Failure
|
Porter, George A.
|
|
1961
|
|
4 |
p. 150-156
|
artikel
|
| 35 |
Betahistine Treatment Improves the Recovery of Static Symptoms in Patients With Unilateral Vestibular Loss
|
Redon, Christine
|
|
2011
|
|
4 |
p. 538-548
|
artikel
|
| 36 |
Bioavailability and Dose Proportionality of Intramuscular Diazepam Administered by Autoinjector
|
Lehmann, Craig
|
|
2008
|
|
4 |
p. 436-444
|
artikel
|
| 37 |
Bioavailability and Metabolism of Mometasone Furoate: Pharmacology versus Methodology
|
Derendorf, Hartmut
|
|
2002
|
|
4 |
p. 383-387
|
artikel
|
| 38 |
Bioavailability of a Sustained-Release Dyphylline Formulation
|
Simons, Keith J.
|
|
1977
|
|
4 |
p. 237-242
|
artikel
|
| 39 |
Bioequivalence of 2 Intravenous Amiodarone Formulations in Healthy Participants
|
Cushing, Daniel J.
|
|
2009
|
|
4 |
p. 407-415
|
artikel
|
| 40 |
Biomarkers in Drug Discovery and Development: From Target Identification through Drug Marketing
|
Colburn, Wayne A.
|
|
2003
|
|
4 |
p. 329-341
|
artikel
|
| 41 |
Blood Pressure Control and Nephroprotection in Diabetes
|
Abbott, Kevin
|
|
2004
|
|
4 |
p. 431-438
|
artikel
|
| 42 |
Book Review: Clinical Neuropharmacology, Vol. 1
|
Procita, Leonard
|
|
1977
|
|
4 |
p. 261-262
|
artikel
|
| 43 |
Book Review: Insulin II. (Handbook of Experimental Pharmacology, Vol. 32, Part II)
|
Procita, Leonard
|
|
1977
|
|
4 |
p. 259-259
|
artikel
|
| 44 |
Book Review: Pathophysiology and Morphology of Myocardial Cell Alterations. (Recent Advances in Studies on Cardiac Structure and Metabolism, Vol. 6)
|
Procita, Leonard
|
|
1977
|
|
4 |
p. 259-260
|
artikel
|
| 45 |
Book Reviews: Antimicrobial Agents and Chemotherapy-1961
|
|
|
1962
|
|
4 |
p. 255-256
|
artikel
|
| 46 |
Book Reviews: Are the Pills Safe?
|
Hutcheon, Duncan E.
|
|
1970
|
|
4 |
p. 283-284
|
artikel
|
| 47 |
Book Reviews: Cancer Chemotherapy
|
|
|
1961
|
|
4 |
p. 192-192
|
artikel
|
| 48 |
Book Reviews: Cure for Cancer. A National Goal
|
Reichert, Philip
|
|
1970
|
|
4 |
p. 282-283
|
artikel
|
| 49 |
Book Reviews: Drugs of Choice 1969-1968
|
|
|
1962
|
|
4 |
p. 255-255
|
artikel
|
| 50 |
Book Reviews: Drug Therapy
|
|
|
1962
|
|
4 |
p. 256-256
|
artikel
|
| 51 |
Book Reviews: Evaluation of Drug Therapy
|
|
|
1961
|
|
4 |
p. 192-192
|
artikel
|
| 52 |
Book Reviews: Legal Medicine Annual-1969
|
Sharpe, William D.
|
|
1970
|
|
4 |
p. 282-282
|
artikel
|
| 53 |
Book Reviews: Pharmacology: The Nature, Action and Use of Drugs
|
|
|
1961
|
|
4 |
p. 192-192
|
artikel
|
| 54 |
Book Reviews: Phrmacology and Therapeutics
|
|
|
1962
|
|
4 |
p. 256-256
|
artikel
|
| 55 |
Book Reviews: Progress in Drug Research, Vol. 2
|
|
|
1961
|
|
4 |
p. 192-192
|
artikel
|
| 56 |
Book Reviews: Psychotropic Drug Response
|
Gagliano, Theodore E.
|
|
1970
|
|
4 |
p. 283-283
|
artikel
|
| 57 |
Book Reviews: Side Effects of Anti-Obesity Drugs
|
|
|
1962
|
|
4 |
p. 256-256
|
artikel
|
| 58 |
Book Reviews: Staining Procedures Used by the Biological Stain Commission
|
|
|
1962
|
|
4 |
p. 256-256
|
artikel
|
| 59 |
Book Reviews: The Physicians' Guide to the MIMPI
|
|
|
1962
|
|
4 |
p. 255-255
|
artikel
|
| 60 |
BookReviews: Venitz J, Sittner W, eds. Appropriate Dose Selection: How to Optimize Clinical Drug Development. Berlin: Springer Verlag; 2007, ISBN-10: 3-540-27867-2, ISBN-13: 978-3-540-27867-2; 222 pp, 37 figures (22 in color), hardcover, $99.00 USA
|
|
|
2007
|
|
4 |
p. 535-535
|
artikel
|
| 61 |
BookReviews: Vogel HG, ed. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays (co-eds: Hock FJ, Maas J, and Mayer D). New York: Springer Verlag; 2006. ISBN-10: 3-540-25638-5, ISBN-13: 978-3-540-25638-0; 889 pp, 131 illustrations, hardcover, 299 euros
|
|
|
2007
|
|
4 |
p. 534-535
|
artikel
|
| 62 |
Book Reviews: 1961-1962 Year Book of Drug Therapy
|
|
|
1962
|
|
4 |
p. 255-255
|
artikel
|
| 63 |
Book Review: Textbook of Medical Physiology, 5th edition
|
Procita, Leonard
|
|
1977
|
|
4 |
p. 260-261
|
artikel
|
| 64 |
Bupropion Has No Effect on Intraocular Pressure or Other Ophthalmologic Parameters After Single or Repeat Doses in Healthy Volunteers
|
Ghibellini, Giulia
|
|
2009
|
|
4 |
p. 489-495
|
artikel
|
| 65 |
Cardiovascular and Respiratory Effects of Profadol in Normal Individuals
|
Pearson, John W.
|
|
1971
|
|
4 |
p. 261-267
|
artikel
|
| 66 |
Cardiovascular Effects of Ketamine in Sick Patients: Should Physicians Be Concerned?
|
Karnwal, Abhishek
|
|
2010
|
|
4 |
p. 482-482
|
artikel
|
| 67 |
Cardiovascular Effects of Prinodolol (LB-46), a Potent Beta-Adrenergic Receptor Antagonist
|
Levy, Joseph V.
|
|
1971
|
|
4 |
p. 249-260
|
artikel
|
| 68 |
Cirrhosis Does Not Affect the Pharmacokinetics and Pharmacodynamics of Clopidogrel
|
Slugg, Peter H.
|
|
2000
|
|
4 |
p. 396-401
|
artikel
|
| 69 |
Clinical Evaluation of a New Theophylline Derivative in the Treatment of Psychiatric Patients
|
Braude, Monique C.
|
|
1966
|
|
4 |
p. 229-231
|
artikel
|
| 70 |
Clinical Investigation in Drugs Designed for Prolonged Release
|
Silson, John E.
|
|
1966
|
|
4 |
p. 208-215
|
artikel
|
| 71 |
Clinical Pharmacological Studies with Haloperidol
|
Dunlop, Edwin
|
|
1966
|
|
4 |
p. 243-246
|
artikel
|
| 72 |
Clinical Pharmacology and Drug Safety
|
von Moltke, Lisa L.
|
|
2005
|
|
4 |
p. 370-370
|
artikel
|
| 73 |
Clinical Pharmacology of the Appeals and Exception Process: The Interface of the Patient, Physician, and Insurance Company to Assure Appropriate Care Under Medicare Part D
|
Blum, Richard S.
|
|
2006
|
|
4 |
p. 394-397
|
artikel
|
| 74 |
Clinical Trials and Lipid Guidelines for Type II Diabetes
|
Prisant, L. Michael
|
|
2004
|
|
4 |
p. 423-430
|
artikel
|
| 75 |
Clonidine Clearance Matures Rapidly During the Early Postnatal Period: A Population Pharmacokinetic Analysis in Newborns With Neonatal Abstinence Syndrome
|
Xie, Hong-Guang
|
|
2011
|
|
4 |
p. 502-511
|
artikel
|
| 76 |
Comparative Effectiveness of Nine Hypnotic Drugs Sleep Laboratory Studies
|
Kales, Anthony
|
|
1977
|
|
4 |
p. 207-213
|
artikel
|
| 77 |
Comparative Target Site Pharmacokinetics of Immediate- and Modified-Release Formulations of Cefaclor in Humans
|
de la Peña, Amparo
|
|
2002
|
|
4 |
p. 403-411
|
artikel
|
| 78 |
Comparisons of the Analgesic Effects of Oral and Intramuscular Oxymorphone and of Intramuscular Oxymorphone and Morphine in Patients with Cancer
|
Beaver, William T.
|
|
1977
|
|
4 |
p. 186-198
|
artikel
|
| 79 |
Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients
|
Borges, Silvana
|
|
2010
|
|
4 |
p. 450-458
|
artikel
|
| 80 |
Constancy in Integrated Cisplatin Plasma Concentrations Among Pediatric Patients
|
Goodisman, Jerry
|
|
2006
|
|
4 |
p. 443-448
|
artikel
|
| 81 |
Correction
|
|
|
1971
|
|
4 |
p. 320-320
|
artikel
|
| 82 |
Correspondence
|
Trautlein, Joseph J.
|
|
1977
|
|
4 |
p. 267-268
|
artikel
|
| 83 |
Correspondence
|
Sly, R. Michael
|
|
1977
|
|
4 |
p. 266-267
|
artikel
|
| 84 |
Cost of Adverse Drug Reactions in a South Indian Tertiary Care Teaching Hospital
|
Rajakannan, Thiyagu
|
|
2012
|
|
4 |
p. 559-565
|
artikel
|
| 85 |
Critique of Prospective Allometric Scaling: Does the Emperor Have Clothes?
|
Bonate, Peter L.
|
|
2000
|
|
4 |
p. 335-340
|
artikel
|
| 86 |
Crossover Dose Escalation Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of R1663, an Oral Factor Xa Inhibitor, in Healthy Male Volunteers
|
Schmitt, Christophe
|
|
2012
|
|
4 |
p. 499-510
|
artikel
|
| 87 |
Decrease of Intracranial Pressure and Weight with Digoxin in Obesity
|
Hannerz, Jan
|
|
2001
|
|
4 |
p. 465-468
|
artikel
|
| 88 |
de la Peña A, Poo K, Milicevic Z, et al. Pharmacokinetic and pharmacodynamic variability of NPL insulin relative to NPH insulin in healthy subjects within an adaptive design protocol. Poster presented at: the American Association of Pharmaceutical Scientists; November 2006; San Antonio, TX
|
Bonate, Peter L.
|
|
2007
|
|
4 |
p. 531-531
|
artikel
|
| 89 |
Determination of the Bioavailability of [14C]-Hexaminolevulinate Using Accelerator Mass Spectrometry After Intravesical Administration to Human Volunteers
|
Klem, B.
|
|
2006
|
|
4 |
p. 456-460
|
artikel
|
| 90 |
Dhea and Dhea-S: A Review
|
Kroboth, Patricia D.
|
|
1999
|
|
4 |
p. 327-348
|
artikel
|
| 91 |
Diabetes Mellitus: An Imperative for Prevention and Intense Management
|
Prisant, L. Michael
|
|
2004
|
|
4 |
p. 394-396
|
artikel
|
| 92 |
Differences Between Japan and the United States in Dosages of Drugs Recently Approved in Japan
|
Nakashima, Kae
|
|
2011
|
|
4 |
p. 549-560
|
artikel
|
| 93 |
Direct Medical Costs of Liquid Intravenous Immunoglobulins in Children, Adolescents, and Adults in Spain
|
Darbà, Josep
|
|
2012
|
|
4 |
p. 566-575
|
artikel
|
| 94 |
Disposition of D-Serine in Healthy Adults
|
Tsai, Guochuan E.
|
|
2008
|
|
4 |
p. 524-527
|
artikel
|
| 95 |
Do Drug Transporter (ABCB1) SNPs Influence Cyclosporine and Tacrolimus Dose Requirements and Renal Allograft Outcome in the Posttransplantation Period?
|
Singh, Ranjana
|
|
2011
|
|
4 |
p. 603-615
|
artikel
|
| 96 |
Does Erythromycin Have Anti-Inflammatory Effects Independent of Its Antimicrobial Action?
|
Oo, Charles
|
|
2012
|
|
4 |
p. 613-614
|
artikel
|
| 97 |
Drugs Released for Clinical Use
|
de Haen, Paul
|
|
1966
|
|
4 |
p. 247-250
|
artikel
|
| 98 |
Drugs Released for Clinical Use
|
De Haen, Paul
|
|
1977
|
|
4 |
p. 263-265
|
artikel
|
| 99 |
Drugs Released for Clinical Use
|
de Haen, Paul
|
|
1969
|
|
4 |
p. 264-266
|
artikel
|
| 100 |
Drugs Released for Clinical Use
|
de Haen, Paul
|
|
1970
|
|
4 |
p. 285-288
|
artikel
|
| 101 |
Drugs Released for Clnical Use
|
de Haen, Paul
|
|
1971
|
|
4 |
p. 318-320
|
artikel
|
| 102 |
Dual Effects of Rifampin on the Pharmacokinetics of Atrasentan
|
Hao Xiong,
|
|
2007
|
|
4 |
p. 423-429
|
artikel
|
| 103 |
Editorial
|
Keefe, Deborah L.
|
|
2003
|
|
4 |
p. 327-328
|
artikel
|
| 104 |
Editorials
|
|
|
1961
|
|
4 |
p. 131-132
|
artikel
|
| 105 |
Effect of Alosetron on the Pharmacokinetics of Alprazolam
|
D'Souza, Doreen L.
|
|
2001
|
|
4 |
p. 452-454
|
artikel
|
| 106 |
Effect of Alosetron on the Pharmacokinetics of Fluoxetine
|
D'Souza, Doreen L.
|
|
2001
|
|
4 |
p. 455-458
|
artikel
|
| 107 |
Effect of CP-690,550, an Orally Active Janus Kinase Inhibitor, on Renal Function in Healthy Adult Volunteers
|
Lawendy, Nervin
|
|
2009
|
|
4 |
p. 423-429
|
artikel
|
| 108 |
Effect of Deanol on Attention in the Mentally Retarded: A Reaction Time Method
|
Fleming, Jack W.
|
|
1962
|
|
4 |
p. 239-244
|
artikel
|
| 109 |
Effect of Different Durations of Ketoconazole Dosing on the Single-Dose Pharmacokinetics of Midazolam: Shortening the Paradigm
|
Stoch, S.A.
|
|
2009
|
|
4 |
p. 398-406
|
artikel
|
| 110 |
Effect of Food on the Oral Bioavailability of Didanosine from Encapsulated Enteric-Coated Beads
|
Damle, Bharat D.
|
|
2002
|
|
4 |
p. 419-427
|
artikel
|
| 111 |
Effect of Food, Type of Food, and Time of Food Intake on Deferasirox Bioavailability: Recommendations for an Optimal Deferasirox Administration Regimen
|
Galanello, Renzo
|
|
2008
|
|
4 |
p. 428-435
|
artikel
|
| 112 |
Effect of Hepatic Impairment on the Pharmacokinetics of Pasireotide (SOM230): Results From a Multicenter Phase I Study
|
Horsmans, Yves
|
|
2012
|
|
4 |
p. 552-558
|
artikel
|
| 113 |
Effect of Low-Dose Baclofen Administration on Plasma Insulin-like Growth Factor-I in Persons With Spinal Cord Injury
|
Bauman, William A.
|
|
2006
|
|
4 |
p. 476-482
|
artikel
|
| 114 |
Effect of Sitagliptin on the Pharmacokinetics of Simvastatin
|
Bergman, Arthur J.
|
|
2009
|
|
4 |
p. 483-488
|
artikel
|
| 115 |
Effect of Steady-State Enoxacin on Single-Dose Pharmacokinetics of Roflumilast and Roflumilast N-Oxide
|
Lahu, Gezim
|
|
2011
|
|
4 |
p. 586-593
|
artikel
|
| 116 |
Effect of the MDR1 C3435T Variant and P-Glycoprotein Induction on Dicloxacillin Pharmacokinetics
|
Putnam, Wendy S.
|
|
2005
|
|
4 |
p. 411-421
|
artikel
|
| 117 |
Effect of Troglitazone on the Pharmacokinetics of an Oral Contraceptive Agent
|
Loi, Cho-Ming
|
|
1999
|
|
4 |
p. 410-417
|
artikel
|
| 118 |
Effect of Venlafaxine versus Fluoxetine on Metabolism of Dextromethorphan, a CYP2D6 Probe
|
Amchin, Jess
|
|
2001
|
|
4 |
p. 443-451
|
artikel
|
| 119 |
Effects of Aspirin When Added to the Prostaglandin D2 Receptor Antagonist Laropiprant on Niacin-Induced Flushing Symptoms
|
Dishy, Victor
|
|
2009
|
|
4 |
p. 416-422
|
artikel
|
| 120 |
Effects of Azimilide on Heart Rate and ECG Conduction Intervals during Sinus Rhythm in Patients with a History of Atrial Fibrillation
|
Pritchett, Edward L. C.
|
|
2002
|
|
4 |
p. 388-394
|
artikel
|
| 121 |
Effects of Commonly Administered Agents and Genetics on Nebivolol Pharmacokinetics: Drug—Drug Interaction Studies
|
Lindamood, Charles
|
|
2011
|
|
4 |
p. 575-585
|
artikel
|
| 122 |
Effects of Dexlansoprazole MR, a Novel Dual Delayed Release Formulation of a Proton Pump Inhibitor, on Plasma Gastrin Levels in Healthy Subjects
|
Weijiang Zhang,
|
|
2009
|
|
4 |
p. 444-454
|
artikel
|
| 123 |
Effects of Dextroamphetamine, Pentobarbital, Chiorphentermine, and Placebo on the Alpha Blocking Response in Normal Subjects
|
Delamonica, Enrique
|
|
1966
|
|
4 |
p. 224-228
|
artikel
|
| 124 |
Effects of Grapefruit Juice on Pharmacokinetic Exposure to Indinavir in HIV-Positive Subjects
|
Shelton, Mark J.
|
|
2001
|
|
4 |
p. 435-442
|
artikel
|
| 125 |
Effects of Milnacipran on Cardiac Repolarization in Healthy Participants
|
Periclou, Antonia
|
|
2010
|
|
4 |
p. 422-433
|
artikel
|
| 126 |
Effects of Orlistat, a Lipase Inhibitor, on the Pharmacokinetics of Three Highly Lipophilic Drugs (Amiodarone, Fluoxetine, and Simvastatin) in Healthy Volunteers
|
Zhi, Jianguo
|
|
2003
|
|
4 |
p. 428-435
|
artikel
|
| 127 |
Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel
|
Small, David S.
|
|
2008
|
|
4 |
p. 475-484
|
artikel
|
| 128 |
Electronic Monitoring of Compliance to Lipid-Lowering Therapy in Clinical Practice
|
Schwed, Ariane
|
|
1999
|
|
4 |
p. 402-409
|
artikel
|
| 129 |
Epidemiology of Diabetes
|
Winer, Nathaniel
|
|
2004
|
|
4 |
p. 397-405
|
artikel
|
| 130 |
Erratum
|
|
|
2012
|
|
4 |
p. NP1-NP3
|
artikel
|
| 131 |
Erratum
|
|
|
1999
|
|
4 |
p. 428-428
|
artikel
|
| 132 |
Erratum
|
|
|
2010
|
|
4 |
p. 483-483
|
artikel
|
| 133 |
Estimating Mass Balance for Inhaled Drugs in Humans: An Example with a VLA-4 Antagonist, IVL745
|
Rohatagi, Shashank
|
|
2004
|
|
4 |
p. 348-358
|
artikel
|
| 134 |
Evaluation of Sodium Colistimethate Aerosol in Gram-Negative Infections of the Respiratory Tract
|
Rose, Harold D.
|
|
1970
|
|
4 |
p. 274-281
|
artikel
|
| 135 |
Flow Cytometric Assessment of Effects of Fluvastatin on Low-Density Lipoprotein Receptor Activity in Stimulated T-Lymphocytes from Patients with Heterozygous Familial Hypercholesterolemia
|
Raungaard, Bent
|
|
2000
|
|
4 |
p. 421-429
|
artikel
|
| 136 |
FTY720 Pharmacokinetics in Mild to Moderate Hepatic Impairment
|
Kovarik, J. M.
|
|
2005
|
|
4 |
p. 446-452
|
artikel
|
| 137 |
Generic Names of New Drugs
|
|
|
1962
|
|
4 |
p. 252-254
|
artikel
|
| 138 |
High-Dose Tybamate Therapy of Heroin Dependence
|
Veress, Frank
|
|
1969
|
|
4 |
p. 232-238
|
artikel
|
| 139 |
Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT)
|
Jacobson, Pamala
|
|
2008
|
|
4 |
p. 485-494
|
artikel
|
| 140 |
How Readily Does Ketorolac Penetrate Cerebrospinal Fluid in Children?
|
Kumpulainen, Elina
|
|
2008
|
|
4 |
p. 495-501
|
artikel
|
| 141 |
Human Breast Milk as a Source of DNA for Amplification
|
Haas, David M.
|
|
2011
|
|
4 |
p. 616-619
|
artikel
|
| 142 |
Influence of Azimilide on CYP2C19-Mediated Metabolism
|
Mouelhi, Mohamed El
|
|
2004
|
|
4 |
p. 373-378
|
artikel
|
| 143 |
Influence of Liver Cirrhosis on the Pharmacokinetics, Pharmacodynamics, and Safety of Tezosentan
|
Dingemanse, Jasper
|
|
2009
|
|
4 |
p. 455-464
|
artikel
|
| 144 |
Innervation and Inhibition of Eccrine and Apocrine Sweating in Man
|
Goodall, McC.
|
|
1970
|
|
4 |
p. 235-246
|
artikel
|
| 145 |
Intense Management of Diabetes Mellitus: Role of Glucose Control and Antiplatelet Agents
|
Mudaliar, Sunder
|
|
2004
|
|
4 |
p. 414-422
|
artikel
|
| 146 |
Interaction between Ketoconazole and Almotriptan in Healthy Volunteers
|
Fleishaker, Joseph C.
|
|
2003
|
|
4 |
p. 423-427
|
artikel
|
| 147 |
In Vitro and In Vivo Assessment of Renal Drug Transporters in the Disposition of Mesna and Dimesna
|
Cutler, M. J.
|
|
2012
|
|
4 |
p. 530-542
|
artikel
|
| 148 |
Is It Really OK to Take This with Food? Old Interactions with a New Twist
|
Wallace, Allison W.
|
|
2002
|
|
4 |
p. 437-443
|
artikel
|
| 149 |
Is Phenacetin the Cause of "Analgesic Nephrotoxicity"?
|
Haley, Thomas J.
|
|
1966
|
|
4 |
p. 193-202
|
artikel
|
| 150 |
Is Phentolamine an Alpha-Adrenergic Blocker?
|
Gould, Lawrence
|
|
1971
|
|
4 |
p. 268-273
|
artikel
|
| 151 |
Kerfuffle!
|
Grasela, Thaddeus H.
|
|
2009
|
|
4 |
p. 386-388
|
artikel
|
| 152 |
Lack of Bioequivalence of Ciprofloxacin When Administered with Calcium-Fortified Orange Juice: a New Twist on an Old Interaction
|
Neuhofel, Ashley L.
|
|
2002
|
|
4 |
p. 461-466
|
artikel
|
| 153 |
Lappin G, Kuhnz W, Jochemsen R, et al. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs. Clin Pharmacol Ther. 2006; 80:213-215
|
|
|
2007
|
|
4 |
p. 531-532
|
artikel
|
| 154 |
Letter to the Editor
|
Sanen, F. J.
|
|
1969
|
|
4 |
p. 267-268
|
artikel
|
| 155 |
Limited Sampling Strategy to Predict AUC of the CYP3A Phenotyping Probe Midazolam in Adults: Application to Various Assay Techniques
|
Kim, Jooran S.
|
|
2002
|
|
4 |
p. 376-382
|
artikel
|
| 156 |
Long-Term Diuretic Therapy with Metolazone of Renal Failure and the Nephrotic Syndrome
|
Paton, Richard R.
|
|
1977
|
|
4 |
p. 243-251
|
artikel
|
| 157 |
Metabolic Disposition and Pharmacokinetics of [14C]-Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects
|
Sadler, Brian M.
|
|
2001
|
|
4 |
p. 386-396
|
artikel
|
| 158 |
Modeling the Relationship Between Drug Lipophilicity and Potential for an Interaction With Orlistat
|
Zhi, Jianguo
|
|
2012
|
|
4 |
p. 595-599
|
artikel
|
| 159 |
Multiple-Dose Pharmacokinetics and Safety of Two Regimens of Quinupristin/Dalfopristin (Synercid®) in Healthy Volunteers
|
Chevalier, Paul
|
|
2001
|
|
4 |
p. 404-414
|
artikel
|
| 160 |
Multiple-Dose Plasma Pharmacokinetic and Safety Study of LY450108 and LY451395 (AMPA Receptor Potentiators) and Their Concentration in Cerebrospinal Fluid in Healthy Human Subjects
|
Jhee, S. S.
|
|
2006
|
|
4 |
p. 424-432
|
artikel
|
| 161 |
Nalorphine Testing for Illegal Narcotic Use in California: Methods and Limitations
|
Terry, James G.
|
|
1962
|
|
4 |
p. 206-210
|
artikel
|
| 162 |
N-2,5-dimethyl-1-pyrrolyl)isonicotinamide in the Treatment of the Inactive Chronically Psychotic Patient
|
McCusker, Kenneth
|
|
1962
|
|
4 |
p. 232-238
|
artikel
|
| 163 |
No Clinically Relevant CYP3A Induction with the Dual Angiotensin-Converting Enzyme/Neutral Endopeptidase Inhibitor, M100240
|
Martin, Nancy E.
|
|
2004
|
|
4 |
p. 379-387
|
artikel
|
| 164 |
No Dose Adjustment on Coadministration of the PDE4 Inhibitor Roflumilast With a Weak CYP3A, CYP1A2, and CYP2C19 Inhibitor: An Investigation Using Cimetidine
|
Böhmer, Gabriele M.
|
|
2011
|
|
4 |
p. 594-602
|
artikel
|
| 165 |
No Pharmacokinetic Interaction Between Lacosamide and Carbamazepine in Healthy Volunteers
|
Cawello, Willi
|
|
2010
|
|
4 |
p. 459-471
|
artikel
|
| 166 |
Objective Assessment of Antitussive Agents in Patients with Chronic Cough
|
Sevelius, Hilli
|
|
1966
|
|
4 |
p. 216-223
|
artikel
|
| 167 |
On the Observed Large Interspecies Overprediction of Human Clearance (“Vertical Allometry”) of UCN-01: Further Support for a Proposed Model Based on Plasma Protein Binding
|
Tang, Huadong
|
|
2006
|
|
4 |
p. 398-400
|
artikel
|
| 168 |
On the Quantitative Evaluation of Pharmacologic Agents
|
Jardetzky, Oleg
|
|
1966
|
|
4 |
p. 203-207
|
artikel
|
| 169 |
Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single-Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel µ-Opioid Receptor Inverse Agonist
|
Nathan, Pradeep J.
|
|
2012
|
|
4 |
p. 464-474
|
artikel
|
| 170 |
Origin and Uses of Primum Non Nocere — Above All, Do No Harm!
|
Smith, Cedric M.
|
|
2005
|
|
4 |
p. 371-377
|
artikel
|
| 171 |
Oxazepam and Meprobamate in Anxious Neurotic Outpatients
|
DeSilverio, Robert V.
|
|
1969
|
|
4 |
p. 259-263
|
artikel
|
| 172 |
Patterns of Drug Utilization in a Neonatal Intensive Care Unit
|
Warrier, Indulekha
|
|
2006
|
|
4 |
p. 449-455
|
artikel
|
| 173 |
Penfluridol, A Peroral Long-Acting Neuroleptic, for the Maintenance Treatment of Schizophrenic Patients Who Relapse
|
Kingstone, E.
|
|
1977
|
|
4 |
p. 252-258
|
artikel
|
| 174 |
Pentylenetetrazol in the Treatment of Geriatric Patients with Disturbed Memory Function
|
Leckman, J.
|
|
1971
|
|
4 |
p. 301-303
|
artikel
|
| 175 |
Pharamacokinetics of Cefazolin in Patients With Renal Failure; Special Reference to Hemodialysis
|
Brogard, J. M.
|
|
1977
|
|
4 |
p. 225-230
|
artikel
|
| 176 |
Pharmacodynamic Effects of a New Potassium-Sparing Diuretic, Amiloride
|
Schwartz, Allan
|
|
1969
|
|
4 |
p. 217-223
|
artikel
|
| 177 |
Pharmacodynamic Modeling of the Effects of Lanreotide Autogel on Growth Hormone and Insulin-Like Growth Factor 1
|
Garrido, María J.
|
|
2012
|
|
4 |
p. 487-498
|
artikel
|
| 178 |
Pharmacogenetic-Based Clinical Scores: A Useful, Simple Tool to Predict Tamoxifen-Based CYP2D6 Phenotype?
|
Fuhr, Uwe
|
|
2010
|
|
4 |
p. 370-372
|
artikel
|
| 179 |
Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA-PWG-PhRMA-DruSafe Workshop
|
Lesko, Lawrence J.
|
|
2003
|
|
4 |
p. 342-358
|
artikel
|
| 180 |
Pharmacokinetic-Pharmacodynamic Modeling of Apratastat: A Population-Based Approach
|
Shu, Cathye
|
|
2011
|
|
4 |
p. 472-481
|
artikel
|
| 181 |
Pharmacokinetics and Biological Activity of Atacicept in Patients With Rheumatoid Arthritis
|
Nestorov, Ivan
|
|
2008
|
|
4 |
p. 406-417
|
artikel
|
| 182 |
Pharmacokinetics and Pharmacodynamics of a Single Bolus of Propofol 2% in Healthy Volunteers
|
Abad-Santos, Francisco
|
|
2003
|
|
4 |
p. 397-405
|
artikel
|
| 183 |
Pharmacokinetics and Pharmacodynamics of a Transdermal Contraceptive Patch and an Oral Contraceptive
|
Devineni, Damayanthi
|
|
2007
|
|
4 |
p. 497-509
|
artikel
|
| 184 |
Pharmacokinetics and Pharmacodynamics of Dexamethasone Sodium-m-Sulfobenzoate (DS) after Intravenous and Intramuscular Administration: A Comparison with Dexamethasone Phosphate (DP)
|
Hochhaus, Günther
|
|
2001
|
|
4 |
p. 425-434
|
artikel
|
| 185 |
Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor−Neprilysin Inhibitor (ARNi)
|
Gu, Jessie
|
|
2010
|
|
4 |
p. 401-414
|
artikel
|
| 186 |
Pharmacokinetics and Pharmacodynamics of Peldesine (BCX-34), a Purine Nucleoside Phosphorylase Inhibitor, following Single and Multiple Oral Doses in Healthy Volunteers
|
Viegas, Tacey X.
|
|
2000
|
|
4 |
p. 410-420
|
artikel
|
| 187 |
Pharmacokinetics and Pharmacodynamics of Recombinant FGF-2 in a Phase I Trial in Coronary Artery Disease
|
Bush, Mark A.
|
|
2001
|
|
4 |
p. 378-385
|
artikel
|
| 188 |
Pharmacokinetics and Safety of Galantamine in Subjects with Hepatic Impairment and Healthy Volunteers
|
Zhao, Qinying
|
|
2002
|
|
4 |
p. 428-436
|
artikel
|
| 189 |
Pharmacokinetics and Safety of Montelukast Oral Granules in Children 1 to 3 Months of Age With Bronchiolitis
|
Kearns, Gregory L.
|
|
2008
|
|
4 |
p. 502-511
|
artikel
|
| 190 |
Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function
|
Khosravan, Reza
|
|
2010
|
|
4 |
p. 472-481
|
artikel
|
| 191 |
Pharmacokinetics of Alcohol Following Single Low Doses to Fasted and Nonfasted Subjects
|
Welling, Peter G.
|
|
1977
|
|
4 |
p. 199-206
|
artikel
|
| 192 |
Pharmacokinetics of an Immediate-Release Oral Formulation of Fampridine (4-Aminopyridine) in Normal Subjects and Patients with Spinal Cord Injury
|
Hayes, K. C.
|
|
2003
|
|
4 |
p. 379-385
|
artikel
|
| 193 |
Pharmacokinetics of a Rivastigmine Transdermal Patch Formulation in Healthy Volunteers: Relative Effects of Body Site Application
|
Lefèvre, Gilbert
|
|
2007
|
|
4 |
p. 471-478
|
artikel
|
| 194 |
Pharmacokinetics of Arundic Acid, an Astrocyte Modulating Agent, in Acute Ischemic Stroke
|
Ishibashi, Hideyasu
|
|
2007
|
|
4 |
p. 445-452
|
artikel
|
| 195 |
Pharmacokinetics of Cisplatin Administered by Continuous Hyperthermic Peritoneal Perfusion (CHPP) to Patients with Peritoneal Carcinomatosis
|
Cho, Hea-Kyoung
|
|
1999
|
|
4 |
p. 394-401
|
artikel
|
| 196 |
Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment
|
Marbury, Thomas
|
|
2009
|
|
4 |
p. 465-476
|
artikel
|
| 197 |
Pharmacokinetics of Intranasal Crushed OxyContin and Intravenous Oxycodone in Nondependent Prescription Opioid Abusers
|
Lofwall, M. R.
|
|
2012
|
|
4 |
p. 600-606
|
artikel
|
| 198 |
Pharmacokinetics of Intravenous Alendronate
|
Cocquyt, Veronique
|
|
1999
|
|
4 |
p. 385-393
|
artikel
|
| 199 |
Pharmacokinetics of Intravenous Levosimendan and Its Metabolites in Subjects With Hepatic Impairment
|
Puttonen, Jaakko
|
|
2008
|
|
4 |
p. 445-454
|
artikel
|
| 200 |
Pharmacokinetics of Ketoprofen Syrup in Small Children
|
Kokki, Hannu
|
|
2000
|
|
4 |
p. 354-359
|
artikel
|
| 201 |
Pharmacokinetics of Oral Tonapofylline and Its Acyl-Glucuronide Metabolite in Patients With Mild and Moderate Hepatic Impairment
|
Li, Zhaoyang
|
|
2012
|
|
4 |
p. 543-551
|
artikel
|
| 202 |
Pharmacokinetics of Sumatriptan Nasal Spray in Children
|
Christensen, Michael L.
|
|
2004
|
|
4 |
p. 359-367
|
artikel
|
| 203 |
Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers
|
Qinying Zhao,
|
|
2011
|
|
4 |
p. 492-501
|
artikel
|
| 204 |
Pharmacokinetics, Safety, and Tolerability of the Novel Oral Direct Renin Inhibitor Aliskiren in Elderly Healthy Subjects
|
Vaidyanathan, Sujata
|
|
2007
|
|
4 |
p. 453-460
|
artikel
|
| 205 |
Pharmacokinetic Study of Infusional Valspodar
|
Ma, Margaret K.
|
|
2002
|
|
4 |
p. 412-418
|
artikel
|
| 206 |
PhRMA Survey on the Conduct of First-in-Human Clinical Trials Under Exploratory Investigational New Drug Applications
|
Karara, Adel H.
|
|
2010
|
|
4 |
p. 380-391
|
artikel
|
| 207 |
Pimozide in Chronic Schizophrenic Patients
|
Huber, Wolfgang
|
|
1971
|
|
4 |
p. 304-309
|
artikel
|
| 208 |
Plasma Level Studies of Penbutolol After Oral Dose in Man
|
Vallner, J. J.
|
|
1977
|
|
4 |
p. 231-236
|
artikel
|
| 209 |
Population Kinetics, Efficacy, and Safety of Dichloroacetate for Lactic Acidosis Due to Severe Malaria in Children
|
Agbenyega, Tsiri
|
|
2003
|
|
4 |
p. 386-396
|
artikel
|
| 210 |
Population Pharmacokinetics and Exposure-Response of Albinterferon Alfa-2b
|
Riggs, Matthew M.
|
|
2012
|
|
4 |
p. 475-486
|
artikel
|
| 211 |
Population Pharmacokinetics and Pharmacodynamics of Brief Etomidate Infusion in Healthy Volunteers
|
Kaneda, Kotaro
|
|
2011
|
|
4 |
p. 482-491
|
artikel
|
| 212 |
Population Pharmacokinetics and Pharmacodynamics of Ciclesonide
|
Rohatagi, S.
|
|
2003
|
|
4 |
p. 365-378
|
artikel
|
| 213 |
Population Pharmacokinetics of Efalizumab (Humanized Monoclonal Anti-CD11a Antibody) Following Long-Term Subcutaneous Weekly Dosing in Psoriasis Subjects
|
Sun, Yu-Nien
|
|
2005
|
|
4 |
p. 468-476
|
artikel
|
| 214 |
Population Pharmacokinetics of Enfuvirtide in HIV-1-Infected Pediatric Patients Over 48 Weeks of Treatment
|
Xiaoping Zhang,
|
|
2007
|
|
4 |
p. 510-517
|
artikel
|
| 215 |
Population Pharmacokinetics of Lamotrigine Adjunctive Therapy in Adults with Epilepsy
|
Grasela, Thaddeus H.
|
|
1999
|
|
4 |
p. 373-384
|
artikel
|
| 216 |
Population Pharmacokinetics of Lamotrigine in Elderly Patients
|
Punyawudho, Baralee
|
|
2008
|
|
4 |
p. 455-463
|
artikel
|
| 217 |
Population Pharmacokinetics of Oxycodone in Children 6 Months to 7 Years Old
|
El-Tahtawy, Ahmed
|
|
2006
|
|
4 |
p. 433-442
|
artikel
|
| 218 |
Possible Usefulness of Azathioprine (Imuran) in Severe Rheumatoid Arthritis
|
Dodson, William H.
|
|
1969
|
|
4 |
p. 251-258
|
artikel
|
| 219 |
Potential Utility of Data-Mining Algorithms for Early Detection of Potentially Fatal/Disabling Adverse Drug Reactions: A Retrospective Evaluation
|
Hauben, Manfred
|
|
2005
|
|
4 |
p. 378-384
|
artikel
|
| 220 |
Preliminary Studies of a New Bronchodilator (WG 253) in Man
|
Griffin, J. P.
|
|
1971
|
|
4 |
p. 280-287
|
artikel
|
| 221 |
Present Status of the Management of Congestive Failure and Advances in Diuretic Therapy
|
|
|
1961
|
|
4 |
p. 160-191
|
artikel
|
| 222 |
Preventing Contrast Nephropathy: What is the Best Strategy? A Review of the Literature
|
Cox, Craig D.
|
|
2004
|
|
4 |
p. 327-337
|
artikel
|
| 223 |
Preventing Type II Diabetes Mellitus
|
Prisant, L. Michael
|
|
2004
|
|
4 |
p. 406-413
|
artikel
|
| 224 |
Prevention of a First Myocardial Infarction
|
Dayspring, Thomas D.
|
|
2001
|
|
4 |
p. 359-367
|
artikel
|
| 225 |
Prokinetic Effects of Erythromycin after Antimotion Sickness Drugs
|
Stewart, John J.
|
|
2000
|
|
4 |
p. 347-353
|
artikel
|
| 226 |
Prospective Allometric Scaling: Does the Emperor Have Clothes?
|
Mahmood, Iftekhar
|
|
2000
|
|
4 |
p. 341-344
|
artikel
|
| 227 |
Race and Ethnicity in the Era of Emerging Pharmacogenomics
|
Harty, Lea
|
|
2006
|
|
4 |
p. 405-407
|
artikel
|
| 228 |
Rebuttal to Mahmood
|
Bonate, Peter L.
|
|
2000
|
|
4 |
p. 345-346
|
artikel
|
| 229 |
Relationship Between Plasma Protease Inhibitor Concentrations and Lipid Elevations in HIV Patients on a Double-Boosted Protease Inhibitor Regimen (Saquinavir/Lopinavir/Ritonavir)
|
Rhee, Martin S.
|
|
2010
|
|
4 |
p. 392-400
|
artikel
|
| 230 |
Reply
|
Bekersky, Ihor
|
|
1999
|
|
4 |
p. 428-428
|
artikel
|
| 231 |
Reply
|
Kovacs, Steven J.
|
|
1999
|
|
4 |
p. 427-427
|
artikel
|
| 232 |
Report of the Secretary-Treasurer
|
Hutcheon, Duncan E.
|
|
1966
|
|
4 |
p. 251-252
|
artikel
|
| 233 |
Response to Dr. Blum
|
Butterweck, Veronika
|
|
2007
|
|
4 |
p. 537-537
|
artikel
|
| 234 |
Review: Clopidogrel Before Elective Percutaneous Coronary Intervention
|
Motovska, Zuzana
|
|
2010
|
|
4 |
p. 373-379
|
artikel
|
| 235 |
Review: Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials
|
Karsdal, M.A.
|
|
2011
|
|
4 |
p. 460-471
|
artikel
|
| 236 |
Review of UCN-01 Development: A Lesson in the Importance of Clinical Pharmacology
|
Fuse, Eiichi
|
|
2005
|
|
4 |
p. 394-403
|
artikel
|
| 237 |
Rifampin: Clinical Studies with a New Antibiotic
|
Brickner, Philip W.
|
|
1969
|
|
4 |
p. 243-250
|
artikel
|
| 238 |
Robert Anthony Hatcher (1868-1944)
|
Gold, Harry
|
|
1971
|
|
4 |
p. 245-248
|
artikel
|
| 239 |
Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: a Dose Escalation Study
|
Lazarus, Hillard M.
|
|
2002
|
|
4 |
p. 395-402
|
artikel
|
| 240 |
Safety Evaluation of Haloperidol in the Treatment of Hyperemesis Gravidarum
|
Van Waes, Amaat
|
|
1969
|
|
4 |
p. 224-227
|
artikel
|
| 241 |
Safety, Tolerability, and Exposure of Ciclesonide Nasal Spray in Healthy and Asymptomatic Subjects With Seasonal Allergic Rhinitis
|
Nave, Ruediger
|
|
2006
|
|
4 |
p. 461-467
|
artikel
|
| 242 |
Safety, Tolerability, and Pharmacokinetics of a Capsule Formulation of DRF-1042, a Novel Camptothecin Analog, in Refractory Cancer Patients in a Bridging Phase I Study
|
Chatterjee, Arani
|
|
2005
|
|
4 |
p. 453-460
|
artikel
|
| 243 |
Safety, Tolerability, and Pharmacokinetics of PTC124, a Nonaminoglycoside Nonsense Mutation Suppressor, Following Single- and Multiple-Dose Administration to Healthy Male and Female Adult Volunteers
|
Hirawat, Samit
|
|
2007
|
|
4 |
p. 430-444
|
artikel
|
| 244 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, for the Treatment of Obesity: Results From a Double-Blind, Placebo-Controlled, Single Oral Dose Study in Healthy Volunteers
|
Addy,, Carol
|
|
2008
|
|
4 |
p. 418-427
|
artikel
|
| 245 |
Salivary Clearance and Urinary Metabolic Pattern of Caffeine in Healthy Children and in Pediatric Patients with Hepatocellular Diseases
|
El-Yazigi, Adnan
|
|
1999
|
|
4 |
p. 366-372
|
artikel
|
| 246 |
Savic RM, Wilkins JJ, Karlsson MO. Un(informativeness) of EBE-based diagnostics. Poster presented at: the American Association of Pharmaceutical Scientists; November 2006; San Antonio, TX
|
|
|
2007
|
|
4 |
p. 532-533
|
artikel
|
| 247 |
Scarpignato C, Di Mario F, eds. Recent advances in gastrointestinal pharmacology and therapeutics. Dig Dis. 2006;24(1-2 theme issue):1-212
|
|
|
2007
|
|
4 |
p. 533-533
|
artikel
|
| 248 |
Selecting Patient-Participants for Drug Investigations
|
Greiner, Theodore
|
|
1962
|
|
4 |
p. 199-205
|
artikel
|
| 249 |
Sequential Analysis of Tacrolimus Dosing in Adult Lung Transplant Patients With ABCB1 Haplotypes
|
Zheng, HongXia
|
|
2005
|
|
4 |
p. 404-410
|
artikel
|
| 250 |
Serum Iron Absorption Tests of a Sustained-Release Form of Oral Iron
|
Mouratoff, George J.
|
|
1961
|
|
4 |
p. 157-159
|
artikel
|
| 251 |
Serum Metabolite/Caffeine Ratios as a Test for Liver Function
|
Jodynis-Liebert, Jadwiga
|
|
2004
|
|
4 |
p. 338-347
|
artikel
|
| 252 |
SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus
|
Ghosh, Raktim Kumar
|
|
2012
|
|
4 |
p. 457-463
|
artikel
|
| 253 |
Short-Term Clinical Exposure Evaluation of a Second-Generation Electrically Heated Cigarette Smoking System
|
Roethig, Hans J.
|
|
2007
|
|
4 |
p. 518-530
|
artikel
|
| 254 |
Short-Term Exposure to Low-Dose Ritonavir Impairs Clearance and Enhances Adverse Effects of Trazodone
|
Greenblatt, David J.
|
|
2003
|
|
4 |
p. 414-422
|
artikel
|
| 255 |
Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C
|
Hawke, Roy L.
|
|
2010
|
|
4 |
p. 434-449
|
artikel
|
| 256 |
Similar Rivastigmine Pharmacokinetics and Pharmacodynamics in Japanese and White Healthy Participants Following the Application of Novel Rivastigmine Patch
|
Lefèvre, Gilbert
|
|
2009
|
|
4 |
p. 430-443
|
artikel
|
| 257 |
Single and Multiple-Dose Pharmacokinetics of an Oral Once-a-Day Osmotic Controlled-Release OROS® (methylphenidate HCl) Formulation
|
Modi, Nishit B.
|
|
2000
|
|
4 |
p. 379-388
|
artikel
|
| 258 |
Single- and Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Japanese Adult Smokers
|
Kikkawa, H.
|
|
2011
|
|
4 |
p. 527-537
|
artikel
|
| 259 |
Single- and Multiple-Dose Pharmacokinetics, Safety, and Tolerability of the Selective α7 Neuronal Nicotinic Receptor Agonist, ABT-107, in Healthy Human Volunteers
|
Othman, Ahmed A.
|
|
2011
|
|
4 |
p. 512-526
|
artikel
|
| 260 |
Single-Dose Pharmacokinetics and Pharmacodynamics of RWJ 67657, a Specific p38 Mitogen-Activated Protein Kinase Inhibitor: A First-in-Human Study
|
Parasrampuria, Dolly A.
|
|
2003
|
|
4 |
p. 406-413
|
artikel
|
| 261 |
Single-Dose Pharmacokinetics of Atrasentan, an Endothelin-A Receptor Antagonist
|
Samara, Emil
|
|
2001
|
|
4 |
p. 397-403
|
artikel
|
| 262 |
Special Issue on Systems Biology: A Users Guide. Nature Reviews: Molecular Cell Biology and Nature Cell Biology; November 2006
|
|
|
2007
|
|
4 |
p. 534-534
|
artikel
|
| 263 |
Steady-State Pharmacokinetics and Tolerability of Modafinil Administered Alone or in Combination with Dextroamphetamine in Healthy Volunteers
|
Hellriegel, Edward T.
|
|
2002
|
|
4 |
p. 450-460
|
artikel
|
| 264 |
Stereoselective Bupropion Hydroxylation as an In Vivo Phenotypic Probe for Cytochrome P4502B6 (CYP2B6) Activity
|
Kharasch, Evan D.
|
|
2008
|
|
4 |
p. 464-474
|
artikel
|
| 265 |
Studies of Cyproheptadine Combined with Dexamethasone
|
Welsh, Ashton L.
|
|
1962
|
|
4 |
p. 223-231
|
artikel
|
| 266 |
Studies to Investigate the Pharmacokinetic Interactions Between Ranolazine and Ketoconazole, Diltiazem, or Simvastatin During Combined Administration in Healthy Subjects
|
Jerling, Markus
|
|
2005
|
|
4 |
p. 422-433
|
artikel
|
| 267 |
Subconjunctival Injection of Triamcinolone Acetonide in the Management of Corneal Graft Rejection and New Vessels
|
Athanasiadis, Ioannis
|
|
2012
|
|
4 |
p. 607-612
|
artikel
|
| 268 |
Successful Projection of the Time Course of Drug Concentration in Plasma During a 1-Year Period From Electronically Compiled Dosing-Time Data Used as Input to Individually Parameterized Pharmacokinetic Models
|
Vrijens, Bernard
|
|
2005
|
|
4 |
p. 461-467
|
artikel
|
| 269 |
Tecarfarin, a Novel Vitamin K Reductase Antagonist, Is Not Affected by CYP2C9 and CYP3A4 Inhibition Following Concomitant Administration of Fluconazole in Healthy Participants
|
Bavisotto, Linda M.
|
|
2011
|
|
4 |
p. 561-574
|
artikel
|
| 270 |
Tegaserod Pharmacokinetics Are Similar in Patients with Severe Renal Insufficiency and in Healthy Subjects
|
Swan, Suzanne K.
|
|
2003
|
|
4 |
p. 359-364
|
artikel
|
| 271 |
Testicular Atrophy from Analgesic Drugs
|
Boyd, Eldon M.
|
|
1970
|
|
4 |
p. 222-227
|
artikel
|
| 272 |
The Analgesic Activity of Propoxyphene Napsylate with and without Aspirin
|
Wang, Richard I. H.
|
|
1971
|
|
4 |
p. 310-317
|
artikel
|
| 273 |
The Comparability of Etanercept Pharmacokinetics in Healthy Japanese and American Subjects
|
Kawai, Shinichi
|
|
2006
|
|
4 |
p. 418-423
|
artikel
|
| 274 |
The Design and Maintenance of Case History Forms in Clinical Trials
|
Herrick, Arthur D.
|
|
1961
|
|
4 |
p. 133-146
|
artikel
|
| 275 |
The Effect of Different Meal Types on the Pharmacokinetics of Darunavir (TMC114)/Ritonavir in HIV-Negative Healthy Volunteers
|
Sekar, Vanitha
|
|
2007
|
|
4 |
p. 479-484
|
artikel
|
| 276 |
The Effect of Glycopyrrolate on Normal Human Small Bowel Activity
|
Fleshler, Bertram
|
|
1962
|
|
4 |
p. 211-214
|
artikel
|
| 277 |
The Effects of Fluvastatin, a CYP2C9 Inhibitor, on Losartan Pharmacokinetics in Healthy Volunteers
|
Meadowcroft, Amy M.
|
|
1999
|
|
4 |
p. 418-424
|
artikel
|
| 278 |
The Influence of Folic Acid Antagonists on the Metabolism of L-Histidine-2(ring)-14C in Man
|
Gaut, Z. N.
|
|
1970
|
|
4 |
p. 247-257
|
artikel
|
| 279 |
The Influence of Mefenamic Acid on Renal Function in the Normal Male Adult
|
Holmes, E. L.
|
|
1969
|
|
4 |
p. 228-231
|
artikel
|
| 280 |
The Influence of Renal Function on Hydroxyurea Pharmacokinetics in Adults With Sickle Cell Disease
|
Yan, Jing-He
|
|
2005
|
|
4 |
p. 434-445
|
artikel
|
| 281 |
The in Vivo Effect of Folinic Acid (Citrovorum Factor) on the Potentiation of the Antibacterial Activity of Sulfisoxazole by Trimethoprim
|
Grunberg, E.
|
|
1970
|
|
4 |
p. 231-234
|
artikel
|
| 282 |
The New Proposed Regulations to Control New Drug Testing
|
Larrick, Geo. P.
|
|
1962
|
|
4 |
p. 245-251
|
artikel
|
| 283 |
The Pharmacogenetics of NAT2 Enzyme Maturation in Perinatally HIV Exposed Infants Receiving Isoniazid
|
Zhu, Rui
|
|
2012
|
|
4 |
p. 511-519
|
artikel
|
| 284 |
The Pharmacokinetics and Pharmacodynamics of Losartan in Continuous Ambulatory Peritoneal Dialysis
|
Pedro, Antonio A.
|
|
2000
|
|
4 |
p. 389-395
|
artikel
|
| 285 |
The Pharmacokinetics and Pharmacodynamics of Ximelagatran, an Oral Direct Thrombin Inhibitor, Are Unaffected by a Single Dose of Alcohol
|
Sarich, Troy C.
|
|
2004
|
|
4 |
p. 388-393
|
artikel
|
| 286 |
The Pharmacokinetics and Safety of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B Virus Infection
|
Sokal, Etienne M.
|
|
2008
|
|
4 |
p. 512-517
|
artikel
|
| 287 |
Therapeutic Equivalence of Prescription Drugs
|
Schameberg, Ira Leo
|
|
1969
|
|
4 |
p. 205-216
|
artikel
|
| 288 |
The Recruitment of Normal Healthy Volunteers: a Review of the Literature on the Use of Financial Incentives
|
Tishler, Carl L.
|
|
2002
|
|
4 |
p. 365-375
|
artikel
|
| 289 |
The Safety and Effectiveness of Newer Antiepileptics: A Comparative Postmarketing Cohort Study
|
Acharya, Nayan V.
|
|
2005
|
|
4 |
p. 385-393
|
artikel
|
| 290 |
The Stereoselective Effects of Bucolome on the Pharmacokinetics and Pharmacodynamics of Racemic Warfarin
|
Matsumoto, Kana
|
|
2001
|
|
4 |
p. 459-464
|
artikel
|
| 291 |
The Targeted Oral, Once-Daily Phosphodiesterase 4 Inhibitor Roflumilast and the Leukotriene Receptor Antagonist Montelukast Do Not Exhibit Significant Pharmacokinetic Interactions
|
Böhmer, Gabriele M.
|
|
2009
|
|
4 |
p. 389-397
|
artikel
|
| 292 |
The Value of Intra-Venous Thymoxamine as a Cutaneous Vasodilator
|
Ramsay, Colin
|
|
1969
|
|
4 |
p. 239-242
|
artikel
|
| 293 |
Thorough QT/QTc Study of Ritonavir-Boosted Saquinavir Following Multiple-Dose Administration of Therapeutic and Supratherapeutic Doses in Healthy Participants
|
Zhang, Xiaoping
|
|
2012
|
|
4 |
p. 520-529
|
artikel
|
| 294 |
Time to Onset of Analgesia and Analgesic Efficacy of Effervescent Acetaminophen 1000 mg Compared to Tablet Acetaminophen 1000 mg in Postoperative Dental Pain: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Study
|
Møller, Philip L.
|
|
2000
|
|
4 |
p. 370-378
|
artikel
|
| 295 |
Time-Variant Increase in Methylprednisolone Clearance in Patients with Acute Respiratory Distress Syndrome: A Population Pharmacokinetic Study
|
Yates, Charles R.
|
|
2001
|
|
4 |
p. 415-424
|
artikel
|
| 296 |
Tolerance and Ionic Effects in Hypertensive Patients of Prolonged Administration of an Aldosterone Antagonist (Amiloride) as Compared with a Thiazide
|
Demanet, J. C.
|
|
1970
|
|
4 |
p. 269-273
|
artikel
|
| 297 |
Ugurel S, Schadendorf D, Pfohler C, et al. In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group. Clin Cancer Res. 2006;12: 5454-5463
|
|
|
2007
|
|
4 |
p. 533-533
|
artikel
|
| 298 |
Urine Drug Screening
|
Valentine, Jimmie L.
|
|
1999
|
|
4 |
p. 425-427
|
artikel
|
| 299 |
Use of In Vitro Drug Metabolism Data to Evaluate Metabolic Drug-Drug Interactions in Man: The Need for Quantitative Databases
|
Rodrigues, David A.
|
|
2001
|
|
4 |
p. 368-373
|
artikel
|
| 300 |
Use of Isocarboxazid in Hypertensive Patients
|
Drapkin, Arnold
|
|
1966
|
|
4 |
p. 237-242
|
artikel
|
| 301 |
Visual-Motor Performance during Lithium Treatment-A Preliminary Report
|
Demers, Robert G.
|
|
1971
|
|
4 |
p. 274-279
|
artikel
|
| 302 |
Wang Y. Visualization of differences among NONMEM estimation methods. Poster presented at: the American Association of Pharmaceutical Scientists; November 2006; San Antonio, TX
|
|
|
2007
|
|
4 |
p. 533-534
|
artikel
|
| 303 |
What Race and Ethnicity Measure in Pharmacologic Research
|
Doyle, Jamie Mihoko
|
|
2006
|
|
4 |
p. 401-404
|
artikel
|
Tijdschrift beschrijving